Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

E-nitiate Biopharmaceuticals (hangzhou) Co., Ltd.

Clinical trials sponsored by E-nitiate Biopharmaceuticals (hangzhou) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New oral drug aims to restore skin color in vitiligo Results expected Dec 2026 (estimated)
  • New pill could bring relief to eczema sufferers Results expected May 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1 Not yet finished but already full! 1 Completed 1
Sort by
  • New oral drug aims to tame severe eczema in teens

    Disease control Completed

    This study tests an experimental oral medication called QY201 in adolescents aged 12 to 17 with moderate to severe atopic dermatitis (eczema). Participants take either 10 mg or 20 mg of QY201 twice daily for 28 days. The main goal is to understand how the drug moves through the b…

    Phase 2 • Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. • Aim: Disease control

    Last updated Jul 19, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space